| BioHazXard87 vs Clive | 22–12 | 64.71% |
| BioHazXard87 vs King | 17–11 | 60.71% |
| BioHazXard87 vs Reina | 10–6 | 62.50% |
| BioHazXard87 vs Law | 11–4 | 73.33% |
| BioHazXard87 vs Kazuya | 12–3 | 80.00% |
| BioHazXard87 vs Yoshimitsu | 10–4 | 71.43% |
| BioHazXard87 vs Jin | 11–3 | 78.57% |
| BioHazXard87 vs Paul | 9–3 | 75.00% |
| BioHazXard87 vs Nina | 8–2 | 80.00% |
| BioHazXard87 vs Heihachi | 5–5 | 50.00% |
| BioHazXard87 vs Alisa | 7–2 | 77.78% |
| BioHazXard87 vs Bryan | 7–1 | 87.50% |
| BioHazXard87 vs Steve | 4–4 | 50.00% |
| BioHazXard87 vs Claudio | 5–2 | 71.43% |
| BioHazXard87 vs Hwoarang | 5–1 | 83.33% |
| BioHazXard87 vs Feng | 5–1 | 83.33% |
| BioHazXard87 vs Eddy | 5–1 | 83.33% |
| BioHazXard87 vs Asuka | 4–1 | 80.00% |
| BioHazXard87 vs Lee | 3–2 | 60.00% |
| BioHazXard87 vs Jun | 4–1 | 80.00% |
| BioHazXard87 vs Victor | 3–2 | 60.00% |
| BioHazXard87 vs Lars | 2–2 | 50.00% |
| BioHazXard87 vs Devil Jin | 1–2 | 33.33% |
| BioHazXard87 vs Leo | 2–1 | 66.67% |
| BioHazXard87 vs Lidia | 1–2 | 33.33% |
| BioHazXard87 vs Lili | 1–1 | 50.00% |
| BioHazXard87 vs Shaheen | 0–2 | 0.00% |
| BioHazXard87 vs Azucena | 2–0 | 100.00% |
| BioHazXard87 vs Raven | 2–0 | 100.00% |
| BioHazXard87 vs Jack-8 | 1–0 | 100.00% |
| BioHazXard87 vs Dragunov | 1–0 | 100.00% |
| BioHazXard87 vs Kuma | 1–0 | 100.00% |
| BioHazXard87 vs Leroy | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.